Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ramucirumab Paclitaxel”

49 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 49 results

Testing effectiveness (Phase 2)Looking for participantsNCT06038578
What this trial is testing

TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer

Who this might be right for
Gastric AdenocarcinomaGastric CancerGastroesophageal Junction Adenocarcinoma
Toray Industries, Inc 146
Post-approval studies (Phase 4)UnknownNCT06169410
What this trial is testing

Ramucirumab Combined With Nab-paclitaxel, Lobaplatin, and S-1 in Neoadjuvant Transformation Therapy for Advanced Gastric Cancer

Who this might be right for
Advanced Gastric Cancer
Yang Jianjun, PhD 140
Testing effectiveness (Phase 2)Study completedNCT02628951
What this trial is testing

Ramucirumab/Paclitaxel as Second-line Treatment in Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma With Integrative Genomic Analysis

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
Samsung Medical Center 62
Large-scale testing (Phase 3)Active Not RecruitingNCT04704934
What this trial is testing

Trastuzumab Deruxtecan for Subjects With HER2-Positive Gastric Cancer or Gastro-Esophageal Junction Adenocarcinoma After Progression on or After a Trastuzumab-Containing Regimen (DESTINY-Gastric04)

Who this might be right for
Gastric Cancer, AdenocarcinomaGastroesophageal Junction Adenocarcinoma
Daiichi Sankyo 490
Early research (Phase 1)Study completedNCT03798626
What this trial is testing

Gevokizumab With Standard of Care Anti-cancer Therapies for Metastatic Colorectal, Gastroesophageal, and Renal Cancers

Who this might be right for
Colorectal CancerGastroesophageal CancerRenal Cell Carcinoma
Novartis Pharmaceuticals 167
Testing effectiveness (Phase 2)Study completedNCT02539225
What this trial is testing

Ramucirumab in Participants With Gastric or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Metastatic Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
Eli Lilly and Company 191
Testing effectiveness (Phase 2)Looking for participantsNCT04660760
What this trial is testing

Ramucirumab and Trifluridine/Tipiracil or Paclitaxel for the Treatment of Patients With Previously Treated Advanced Gastric or Gastroesophageal Junction Cancer

Who this might be right for
Clinical Stage III Gastric Cancer AJCC v8Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage IV Gastric Cancer AJCC v8+28 more
Academic and Community Cancer Research United
Not applicableUnknownNCT04915807
What this trial is testing

Real-world Data (RWD) of Ramucirumab Plus Paclitaxel

Who this might be right for
Gastric CancerGastroesophageal Junction Adenocarcinoma
Hallym University Medical Center 222
Large-scale testing (Phase 3)Study completedNCT02898077
What this trial is testing

Paclitaxel With or Without Ramucirumab (LY3009806) in Participants With Gastric or Gastroesophageal Cancer

Who this might be right for
Gastroesophageal Junction AdenocarcinomaGastric Adenocarcinoma
Eli Lilly and Company 440
Not applicableLooking for participantsNCT06490159
What this trial is testing

Predicting Peripheral Neuropathy of Paclitaxel for Gastric Cancer

Who this might be right for
Gastric CancerChemotherapy-induced Peripheral NeuropathyPaclitaxel+1 more
City of Hope Medical Center 150
Testing effectiveness (Phase 2)Looking for participantsNCT06043427
What this trial is testing

Paclitaxel and Ramucirumab +/- Zanidatamab in HER2 Postive Advanced Gastroesophageal Adenocarcinoma

Who this might be right for
Gastroesophageal Adenocarcinoma
Canadian Cancer Trials Group 168
Not applicableStudy completedNCT04192734
What this trial is testing

Retrospective Study of Ramucirumab and Paclitaxel in Gastric or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric or Gastroesophageal Junction Adenocarcinoma
Hallym University Medical Center 1,063
Testing effectiveness (Phase 2)UnknownNCT04888663
What this trial is testing

Study of Ramucirumab, Trastuzumab and Paclitaxel in Patients With HER2-positive Recurrent/Metastatic Gastric Cancer (HER-RAM Study)

Who this might be right for
Recurrent/Metastatic Gastric Cancer
Yonsei University 50
Large-scale testing (Phase 3)Study completedNCT03081143
What this trial is testing

Ramucirumab Plus FOLFIRI Versus Ramucirumab Plus Paclitaxel in Patients With Advanced or Metastatic Gastric Cancer, Who Failed One Prior Line of Palliative Chemotherapy

Who this might be right for
Advanced Gastric or EGJ Cancer
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 429
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07669740
What this trial is testing

A Study on the Efficacy and Safety of Sintilimab Combined With Ramucirumab and Paclitaxel in the Treatment of Gastric Cancer Patients With Short-term Recurrence After Adjuvant Therapy

Who this might be right for
Gastric Cancer (Diagnosis)
The First Affiliated Hospital with Nanjing Medical University 30
Early research (Phase 1)Study completedNCT03193918
What this trial is testing

Study of Crenolanib With Ramucirumab and Paclitaxel for Advanced Esophagogastric Adenocarcinoma

Who this might be right for
Esophagogastric Adenocarcinoma
Arog Pharmaceuticals, Inc. 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT07763171
What this trial is testing

Paclitaxel, Ramucirumab and Tislelizumab Switch Maintenance in Advanced HER2-negative and PD-L1 TAP Score of 5 or More Advanced Gastroesophageal Adenocarcinoma

Who this might be right for
Gastroesophageal Adenocarcinoma
Gruppo Oncologico del Nord-Ovest 244
Testing effectiveness (Phase 2)Study completedNCT03745430
What this trial is testing

RAmucirumab Combined wIth Standard Nab-paclitaxel and Gemcitabine as First-line Chemotherapy in Patients With Advanced Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Adenocarcinoma
Hellenic Cooperative Oncology Group 54
Not applicableApproved For MarketingNCT02307812
What this trial is testing

Ramucirumab Use in Combination With Paclitaxel in Gastric or Gastroesophageal Junction Adenocarcinoma; Temporary Authorization for Use (ATU) in France

Who this might be right for
Gastric CancerGastroesophageal Junction Adenocarcinoma
Eli Lilly and Company
Early research (Phase 1)Looking for participantsNCT06675136
What this trial is testing

Nab-Paclitaxel PIPAC in Combination With Paclitaxel and Ramucirumab for the Treatment of Stomach Cancer With Peritoneal Metastases

Who this might be right for
Clinical Stage IVB Gastric Cancer AJCC v8Metastatic Gastric AdenocarcinomaMetastatic Malignant Neoplasm in the Peritoneum
City of Hope Medical Center 30
Next Page
116